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WHAT’S NEW? 5 
 There is a need to increase the number of women attending glucose testing after gestational 6 
diabetes. Higher attendance will enable earlier diagnosis and management of diabetes and 7 
improve long-term outcomes. 8 
 This is the first qualitative review focusing on barriers and facilitators to screening attendance. 9 
 We found that factors could affect either mothers’ motivation or opportunity to attend. 10 
 Some influences related to the healthcare system (relationship with healthcare and logistics 11 
of the appointment and test) while others were personal (concern about diabetes and family-12 
related practicalities). 13 
 We developed ten recommendations to increase screening attendance based on the barriers 14 
and facilitators identified.  15 
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Aims: Many women do not attend recommended glucose testing following a pregnancy affected by 2 
gestational diabetes. We aimed to synthesise the literature regarding the views and experiences of 3 
women with a history of gestational diabetes on postpartum glucose testing, focussing on barriers and 4 
facilitators to attendance. 5 
Methods: We systematically identified qualitative studies that examine women’s experiences 6 
following gestational diabetes relating to glucose testing (diabetes screening) or experience of 7 
interventions to promote uptake of testing. We conducted a thematic synthesis to develop descriptive 8 
and then analytical themes, then developed recommendations to increase uptake based on the 9 
findings. We evaluated the quality of each study and the confidence that we had in the 10 
recommendations using published checklists. 11 
Results: We included 16 articles after screening 23,160 citations and 129 full texts. We identified four 12 
themes of influences relating to the healthcare system and personal factors that affected both ability 13 
and motivation to attend: relationship with healthcare, logistics of appointments and tests, family-14 
related practicalities, and concern about diabetes. We developed ten recommendations addressing 15 
diabetes risk information and education, and changes to healthcare systems to promote increased 16 
attendance at screening in this population, most with high or moderate confidence. 17 
Conclusions: We have identified a need to improve women’s understanding about type 2 diabetes and 18 
gestational diabetes, and to adjust healthcare provision during and after pregnancy to decrease 19 
barriers and increase motivation for testing. Encouraging higher uptake by incorporating these 20 
recommendations into practice will enable earlier management of diabetes and improve long-term 21 




Gestational diabetes (GDM) is an increasingly common disorder, with ~14% of pregnancies affected 2 
worldwide [1]. In addition to increasing the risks of pregnancy complications that affect both mother 3 
and baby, it is associated with increased risk of cardiometabolic disease after pregnancy; this is often 4 
overlooked [2]. Specifically, women with GDM are eight-times more likely to develop Type 2 diabetes 5 
than unaffected women [3], and this risk is highest during the first five years postpartum [4]. Along 6 
with diabetes risk factors such as high body mass index and older age, maternal and pregnancy-related 7 
factors such as poorer pregnancy glycaemic control that needs to be managed with insulin have been 8 
suggested to further increase the risk of developing diabetes after GDM [5,6]. 9 
National and international guidelines recommend that pregnant women are screened for glucose 10 
abnormalities at one to three months postpartum to exclude persisting diabetes [7,8]. Women should 11 
then be regularly screened according to previous test results in order to monitor glucose levels and to 12 
identify those at highest risk of progressing to diabetes [7,8]. Earlier detection of Type 2 diabetes and 13 
effective management of ‘pre-diabetes’ decreases exposure to hyperglycaemia and hence reduces 14 
risk of longer-term complications and all-cause mortality [9]. There is currently variation between 15 
guidelines about which screening tests and schedules to use. For example, the American Diabetes 16 
Association recommends using the 75g oral glucose tolerance test (OGTT) at the first postpartum test 17 
followed by either a fasting plasma glucose (FPG) test, OGTT or HbA1c at least every three years [7]. In 18 
2015, the National Institute for Health and Care Excellence (NICE) advised that women in the UK 19 
should be screened using FPG postpartum followed by annual HbA1c testing, and should not be 20 
routinely offered an OGTT [8].  21 
Frequency of postpartum screening varies by population but remains suboptimal; many studies report 22 
just 50% uptake [10–13]. Younger women with other children and of lower socioeconomic status 23 
attend less frequently, particularly if they received little perinatal care or their GDM was managed by 24 
diet alone [13]. Not all women who access postpartum care after GDM receive appropriate diabetes 25 
screening [13]. These observations are consistent with lower long-term engagement in behaviour 26 
change interventions in women with GDM compared to other populations [14], highlighting the 27 
difficulty engaging this population in interventions aimed at reducing diabetes risk. A systematic 28 
review of both qualitative studies and surveys found that healthcare seeking after GDM can be 29 
constrained by the maternal role (meaning prioritising the needs of children and constraints 30 
associated with childcare), failures of the healthcare system, and women’s perspectives towards 31 
testing [15]. However, only studies published up to 2013 were included and general care, rather than 32 
glucose testing, was considered.  33 
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In light of recently-published studies about screening plus changing guidelines for gestational and Type 1 
2 diabetes diagnosis and management [7,8,16–19], we have systematically synthesised the literature 2 
up to September 2017 regarding the views and experiences of women with a history of GDM on 3 
follow-up glucose testing. We particularly focused on barriers and facilitators to attendance. 4 
Furthermore, we have developed recommendations to adjust testing protocols or inform 5 
interventions for improving long-term follow-up based on the findings. 6 
 7 
METHODS 8 
Details of the protocol for this systematic review were registered on PROSPERO (CRD42018092386; 9 
available from www.crd.york.ac.uk/prospero).  10 
Methods for the systematic search and analysis were the same as those used for a parallel review, 11 
synthesising views on a healthy lifestyle after a pregnancy affected by GDM [20].  12 
SEARCH STRATEGY 13 
In brief, the search strategy shown in Table S1 was used to search CINAHL, the Cochrane Library, 14 
Embase, MEDLINE and PsychINFO electronic databases. This was developed for a group of literature 15 
reviews concerning GDM. There were no language or other restrictions. We also screened reference 16 
lists of included studies for citations not identified by this search. 17 
STUDY SELECTION  18 
We included peer-reviewed journal articles that examine women’s experiences following GDM 19 
relating to postpartum glucose tolerance testing or Type 2 diabetes screening, or experience of 20 
interventions to promote screening. All qualitative and mixed methods studies were eligible. We 21 
excluded studies exclusively reporting views of healthcare providers and about postpartum lifestyle in 22 
order to focus on screening.  23 
After removing duplicates, R.D. or R.W. assessed all titles and abstracts against these selection criteria. 24 
We used an overlap of ~10% to ensure agreement between decisions. Any differences were discussed 25 
with all authors and the selection criteria were refined and elaborated accordingly. R.D. and R.F. then 26 
acquired full text articles and reassessed them against these criteria, again with 10% overlap.  27 
QUALITY ASSESSMENT  28 
R.F. used the Critical Appraisal Skills Programmes (CASP) checklist for qualitative research [21] to 29 
assess the quality of the qualitative research in each study, with discussion with R.D. Scores of 0, 0.5 30 
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and 1 were awarded for answering ‘no’, ‘unclear’ and ‘yes’ to each of the ten questions. We did not 1 
exclude studies based on quality in order to make use of all available information. We did, however, 2 
take the quality of the studies into account when developing our themes and recommendations, and 3 
assessed the contribution of lower quality studies to the findings in Tables S3 and S4.  4 
QUALITATIVE SYNTHESIS  5 
We conducted a thematic synthesis [22] with the aid of NVivo 11. Text and tables labelled as ‘Results’ 6 
(or equivalent) that resulted from qualitative methods were used as data. After familiarising ourselves 7 
with the data, R.D. and R.F. formed a coding frame and used this to develop descriptive themes. Both 8 
authors extracted and coded data, including independently coding a subset of papers at multiple 9 
stages to check consistency. In the second stage, concepts were translated from one study and 10 
category to another by making summaries and comparisons, and new concepts developed as 11 
illustrated in Fig 1. R.D. and R.F. considered these independently, then together and finally refined the 12 
analytical themes through discussion with the wider research team. 13 
We have presented illustrative quotations from the original studies as part of our explanation of the 14 
analytical themes to allow the primary data to be considered. We specify whether the quotations were 15 
from screened or unscreened women if this was included in the primary data. We have considered 16 
our perspectives on the analysis and results as clinical or non-clinical researchers based in the UK. R.D. 17 
has undertaken postgraduate training in public health and completed the research as part of her 18 
doctoral studies; R.F. is a medical student; R.W. is an academic general practice registrar; and S.G. and 19 
J.U-S. are both academic general practitioners with qualitative research experience.  20 
RECOMMENDATIONS FOR PROMOTING SCREENING 21 
From the analytical findings, we developed recommendations that aimed to address the behaviours 22 
or beliefs that hindered screening attendance and to make use of facilitators. We aligned each 23 
recommendation with the standardised behaviour change technique (BCT) taxonomy (v1) to enable 24 
greater consideration of the mechanism by which the recommendations could have an effect [23]. We 25 
used the Grading of Recommendations Assessment, Development and Evaluation-Confidence in 26 
Evidence from Reviews of Qualitative research (GRADE-CERQual) approach to evaluate our confidence 27 
in each of these recommendations [24]. GRADE-CERQual considers the relevance, coherence, 28 
adequacy and methodological limitations of data contributing to each recommendation, therefore 29 





We included 16 qualitative papers after screening 23,160 citations and reviewing 129 full texts (Fig 2). 1 
Table 1 shows the characteristics of these studies. Two papers published by Rafii et al. in 2017 2 
reported data from the same set of interviews but used different analysis methods [25,26]. The 3 
median number of participants was 22 (interquartile range 12 to 31) and 746 postpartum women are 4 
represented overall. 53% of these participants attended testing (97/184, based on seven studies 5 
reporting attendance). All but one used interviews, which were most frequently conducted face-to-6 
face. Most were set in high-income countries and some recruited minority populations; where mixed 7 
populations were recruited, often over half of participants were White European. Average age was 8 
~35 years (range 24 to 56 years). Where reported, the majority of each population was married; use 9 
of insulin during pregnancy, family history of diabetes and being overweight were common. Views 10 
towards the first postpartum test or general testing were considered and, correspondingly, data were 11 
collected between six weeks and nine years after pregnancy.  12 
We found most of the studies to be good quality (mean CASP score 7.6/10), as detailed in Table S2. 13 
Two studies scored below 6/10 because they did not report use of rigorous qualitative methods 14 
[27,28]. The value of some studies to this review (CASP question 10) was unclear or low because they 15 
presented mixed results from both mothers and healthcare providers and some only had a small 16 
section about testing. The relationship between the researcher and participants and ethical issues 17 
were poorly considered in general. 18 
Barriers and facilitators to attending screening after GDM were translated into four themes and 13 19 
subthemes (underlined) that are described below. Although not discrete categories, we organised the 20 
themes into quadrants according to the degree to which they related to the healthcare system or were 21 
personal factors, and the degree to which they supported attendance (permissive factors) or 22 
influenced attitudes towards testing (motivational factors). This is summarised in Fig 3 and the studies 23 
that contributed to each theme are shown in Table S3. Influences were reported from the perspective 24 
of GDM-affected participants but not all participants were influenced by each factor.  25 
RELATIONSHIP WITH HEALTHCARE 26 
Participants’ interaction with the healthcare system influenced their intentions towards screening.  27 
The behaviour of clinicians could conflict with or reinforce prioritisation of screening. Pregnancy and 28 
postpartum care could imply that GDM and the associated diabetes risk were not important after 29 
delivery therefore there was no need for further testing. For example, the message that GDM would 30 
resolve after delivery could appear inconsistent with messages about postpartum screening: “…my 31 
diabetes midwife said it normally goes away after the pregnancy so I didn’t get anything afterwards” 32 
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[29]. Women were also confused because glucose monitoring and dietary restrictions stopped 1 
immediately: “I sat there in the hospital eating a big huge piece of chocolate cake…” [30]. Furthermore, 2 
some clinicians had “no time” for glucose testing [31] but focused on the baby or non-diabetes 3 
maternal care at postpartum appointments. On the other hand, clinicians ‘promoting’ follow-up [32] 4 
helped women to understand its importance, for example, “I think that [postnatal follow-up] was 5 
explained to me both pre and post that that needed to happen. It was explained by both the hospital 6 
and the GP” [screened] [33]. 7 
Participants additionally commented on the process of booking tests. Many were surprised to discover 8 
that it was their responsibility rather than doctors’ and that missed appointments were not chased. 9 
They often needed to act on generic information, such as “…[the leaflet] said it was something I was 10 
supposed to take care of myself…” [screened] [31]. Although many did arrange the test, some 11 
considered that invitations and reminders should come from the doctors: “Well, it would be a lot 12 
easier if I got a letter that said, now it’s time – like they do for that cervix cancer screening” [screened] 13 
[31]; proactive clinicians encouraged attendance: “…[my doctor] even wrote it down in my insurance 14 
booklet” [screened] [25]. Participants would be reassured to know that GPs were involved in this part 15 
of their care because “…You tend to forget… so much occurs after the childbirth” [34]. At an extreme, 16 
some women perceived that their GP did not know about routine follow-up care after GDM (“Even for 17 
blood test I had to tell him I have to do a blood test for diabetes” [screened] [33]), or explicitly gave 18 
incorrect advice. One participant concluded that “[GPs] don’t really understand it, GDM, at all” 19 
[screened] [33].  20 
In addition, continuity of healthcare was frequently discussed. Some women were distressed by lack 21 
of continuity: “…You see all different [doctors] and then they didn’t have my record and… everybody 22 
just seems so confused here, like they don’t know what’s going on with their patient” [attended visit] 23 
[35]. Conversely, consistency in relationships meant that they knew and trusted their clinicians, and 24 
could feel safe with predictable appointments: “It meant a lot to me that I didn’t have to see a new 25 
person every time I was there. That would definitely have made me feel all confused – it wouldn’t 26 
have been fun at all…” [31]. Fragmented care was particularly obvious between pregnancy and 27 
returning to the GP postpartum, where Bernstein et al. referred to a ‘chasm between specialities’ and 28 
‘professional silos’ [36]. Consequently, some needed to take on the role of ‘information broker’ [33] 29 
and communicate their pregnancy history with their GP; electronic medical records were not sufficient 30 
[33,36]. Additionally, Bennett et al. reported that relationships built with administrative staff 31 
facilitated follow-up: “…when I called to reschedule [the clerk]’s like, ‘Oh, I was hoping you’d bring the 32 
baby so I could see him.’ So I told her I’d bring him” [screened] [35]. 33 
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Finally, clinicians played an important role in the ability to understand diabetes risk. A lack of patient-1 
focus prevented participants from asking questions about GDM because there was only time for 2 
clinicians’ agenda in consultations (“She [GP] basically said don’t eat any carbs, any sugar, don’t eat 3 
any fruit… I was sort of like a bit overwhelmed. I came home and I just cried because there is nothing 4 
I can eat now…” [not screened] [33]), or because it was explained using medical terminology that they 5 
could not understand [33]. Some clinicians were too keen to refer them to websites and/or leaflets. 6 
Inability to learn about GDM could leave women anxious and uninformed about their risk of diabetes 7 
or the need for screening. Several identified the need for “good education antenatally as well as once 8 
you’ve had the baby [and] your brain’s working again…” [32]. 9 
THE APPOINTMENT AND TEST 10 
Practical aspects of both the appointment and the glucose test itself affected opportunity to attend.  11 
Logistics of going to and being at the appointment could create several barriers to attendance. These 12 
included the appointment time, needing to travel long distances or needing to use public transport, 13 
which one participant experienced all of: “It was a long and tiring day and I was exhausted when I got 14 
back home” [37]. Some factors were inherent to current OGTT procedures such as the long 15 
appointment: “because it took two hours of my time I kept putting it off” [28]. Furthermore, lack of 16 
health insurance or the ability to pay for testing prevented attendance: “I don't really need [testing]… 17 
only because of how much it costs, since we are in a terrible financial position” [not screened] [26]. 18 
Women found the testing procedure unpleasant or did not understand its purpose therefore wanted 19 
to avoid having to go through it. In particular, many reported that fasting then drinking a glucose 20 
solution made them feel ill, and some disliked needles. Some respondents indicated that they did not 21 
understand how the test worked, meaning one participant ate breakfast so had to come back another 22 
time [35], and another questioned the procedure saying, “…How can you give somebody sugar to drink 23 
and then you’re going to have to test it? They’re definitely going to find the sugar” [36]. Several 24 
suggested using more pleasant tests [28]. 25 
FAMILY-RELATED PRACTICALITIES 26 
Respondents reported various personal challenges to attending screening tests. As illustrated by the 27 
response “…everything is about your baby…” [31], these tended to relate to children. Bernstein et al. 28 
said that ‘most women opt to plan activities around the needs of the newborn, not around the needs 29 
of the medical care system’ [36] therefore if the two were not compatible, they did not attend. 30 
Mothers said that needing to care for their child prevented screening attendance: “I don’t think there 31 
was anything that made me hesitate other than, you know, life with a newborn and two other 32 
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children…” [38]. Several mentioned their schedules: some reported that a new baby led to a lack of a 1 
schedule (“…[getting things] done happens in the window of opportunity on the spur of the moment” 2 
[32]) whereas others struggled around feeding and sleep routines. Importantly, the clinic was not seen 3 
to be a suitable place to wait with children or to breastfeed. Bennet et al. reported that few women 4 
brought their children to the test [35]; when others spoke about the need to find childcare, it appeared 5 
that bringing them was not considered an option (due to the anticipated challenges of the waiting 6 
room and during the procedure). ‘A “separate room to facilitate breast feeding, toys for kids, nappy 7 
changing facilities” at the testing centres may also facilitate screening attendance’ [28]. This theme 8 
was more important in unusual or unexpected circumstances: “I guess [I didn’t come be]cause [I was] 9 
seeing the baby [at the hospital] every day… It’s the only thing I did…” [not screened] [35]. 10 
Unsurprisingly, adapting to life with the baby was difficult and women described feeling “just tired… 11 
because I’m burnt out, frustrated” [not screened] [35] and that “life is stressful. With a new baby, 12 
mum gets no sleep and has no energy and… may be feeling overwhelmed” [37]. In the context of 13 
“trying to get showers in and get food in is an issue right now” [screened] [35], mothers’ own health 14 
and arranging testing were forgotten or simply too much, although many intended to go at a later 15 
date or when things were more under control (“I had no time to go… Always I tell I do it tomorrow… 16 
But I do not gone again, because I have to do another duty…” [not screened] [26]). 17 
Furthermore, the support that women received at home affected their ability to take time away from 18 
childcare and attend testing: several mentioned that their husbands or parents had looked after the 19 
children whereas others did not have this option. One participant explained that “Because of my 20 
children, I cannot go out much… There is no one to keep an eye on them while I'm gone” [not 21 
screened] [26]. 22 
Finally, the need to work presented a further barrier to attendance because women were not able to 23 
take time away for the test: “I couldn’t leave work because they could take it away and I knew the 24 
situation I was in, I needed to work” [36], and it presented another demand on their time: “…I’ve been 25 
running around trying to get stuff done before I go back to work” [screened] [35].  26 
CONCERN ABOUT DIABETES 27 
Lastly, participants’ level of concern regarding diagnosis of diabetes was a key factor affecting 28 
motivation to attend screening. 29 
Some participants were unconcerned about discovering their glucose status so were not motivated to 30 
attend screening. This represented apathy (“could not be bothered” and “having a slack attack” [37]) 31 
or a lack of urgency [33]. Others were untroubled by the possibility of a diabetes diagnosis because 32 
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they did not deem themselves to be at risk. One denied her diagnosis, which was outlined in her 1 
medical record, saying “My glucose level was not too high. It wasn’t GDM…” [not screened] [25]. Some 2 
had evaluated that they did not have diabetes due to reassuring results of self-monitoring that they 3 
continued postpartum (concluding “everything is normal” [not screened] [35]) and because they felt 4 
healthy or were “very careful and compliant” with lifestyle recommendations [not screened] [25]. 5 
Other women were unconcerned but were nevertheless tested as screening coincided with other 6 
aspects of postpartum care or marked ‘closure with their care’ [35]. 7 
Concern regarding a diabetes diagnosis and understanding the need for management most often 8 
encouraged screening. In particular, understanding the significance of diabetes was a motivator to 9 
attend (“…so I am afraid of diabetes… That’s why I’m screening” [screened] [25]). This could be 10 
reinforced through knowing friends and family with diabetes, or their own experience: one participant 11 
considered the implications of a diagnosis very seriously, saying “…I would have to ask for counselling 12 
or something to help me cope with that…” [36]. Additionally, plans for future pregnancies motivated 13 
some to be tested ‘…to avoid any complications that might jeopardize her ability to do this 14 
successfully’ [38]. Abnormal results of self-monitoring increased concern about diabetes risk and 15 
stimulated formal screening.  16 
Occasionally, women’s fear of diagnosis of diabetes discouraged screening as they tried to hide from 17 
it: “It’s, like, oh my gosh, I don’t want to have it. And so, I guess, in my mind, it’s been, if I don’t get 18 
checked, maybe I won’t develop it” [38].  19 
RECOMMENDATIONS FOR PROMOTING POSTPARTUM TESTING 20 
In light of the findings, we developed recommendations for approaches to encourage attendance at 21 
glucose testing, both at six weeks postpartum and beyond (Table 2). These reference BCTs and are 22 
directed at both women with GDM (such as ‘5.1 Information about health consequences’) and 23 
clinicians or the healthcare system (such as ‘12.1 Restructuring the physical environment’) [23]. We 24 
had high confidence in three, moderate confidence in six and low confidence in one 25 
recommendation(s) in accordance with the GRADE-CERQual assessment; this is summarised in Table 26 
2 and fully explained in Table S4. 27 
 28 
DISCUSSION 29 
Through a synthesis of qualitative studies, we have shown how multiple healthcare and personal 30 
factors influence attendance at postpartum glucose testing after GDM. These factors could act as both 31 
barriers and facilitators (although barriers were dominant in the studies we included), and some 32 
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influenced practical aspects whereas others affected desire or motivation to attend. Those with high 1 
intention for testing may be able to overcome certain logistical barriers and attend, whereas these 2 
same barriers may stop less motivated women. We focussed on postpartum testing yet several 3 
influences were clearly being established during pregnancy. Accordingly, we have identified and 4 
assessed our confidence in multiple approaches to increase attendance.  5 
STRENGTHS AND LIMITATIONS 6 
We completed a rigorous literature search and qualitative synthesis as a multidisciplinary team for 7 
this review. In order to minimise our bias as researchers, we discussed the analysis and used CASP and 8 
CERQual checklists when evaluating the quality of studies that contributed to the synthesis and our 9 
confidence in the resulting recommendations. We utilised the BCT taxonomy to describe strategies to 10 
promote screening in this population. Additionally, we included perspectives from different 11 
populations and healthcare systems and found influences that could be relevant to any setting. For 12 
example, the cost of testing mostly related to paying for the test yet in settings with free healthcare, 13 
costs associated with travel (e.g. parking charges) may be a barrier. 14 
Some of the 16 papers we included were poor quality and/or only contributed a small amount to the 15 
review findings. There was inevitable selection bias whereby people with stronger views were more 16 
likely to participate than those without. However, participants included both women who had 17 
attended screening and those that had not. Our interpretations were also limited by the data that 18 
were reported: we sought to focus on attendance at screening rather than postpartum care seeking 19 
more generally, but were not always able to distinguish between the two. Similarly, use of OGTT, FPG 20 
or HbA1c tests was not reported, although descriptions from participants suggest most were offered 21 
an OGTT. Fewer studies specifically discussed how to increase screening attendance therefore our 22 
recommendations were primarily suggestions of how to overcome barriers. In addition, it was difficult 23 
to identify patterns in influences. For example, although some will be similar, it is likely that influences 24 
will vary between the first test at six weeks postpartum and diabetes screening several years after 25 
pregnancy yet it was also often unclear how long after pregnancy participants referred to. We were 26 
also not able to consider individual-level interactions such as whether first-time mothers were more 27 
influenced by certain factors than experienced mothers. Although participants criticised or identified 28 
gaps in their care (or praised the system), the extent to which this contributed to their decision to 29 
attend screening or not is not clear.  30 
COMPARISON TO OTHER STUDIES  31 
Although we analysed the data using thematic synthesis rather than a framework-based approach, 32 
the influences we identified operated in a way similar to those described in the COM-B model of 33 
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behaviour [39]. On one side, we identified motivational influences: emotions such as worry about 1 
diabetes and relationships with healthcare. On the other side, our permissive themes could be 2 
described as opportunity and capability to attend, where we consider external factors that prompt or 3 
inhibit screening, and psychological and physical potential. 4 
Our findings echo many of those identified by Van Ryswyk et al. 2015 [15]. While their review covered 5 
the wider context of healthcare seeking after GDM, we were able to develop understanding 6 
specifically related to postpartum testing in addition to attending appointments. For example, we 7 
were able to explain their finding that “Some women felt a sense of postpartum abandonment after 8 
the intensive antenatal management of their GDM…” (page 144) and how it related to postpartum 9 
testing. Additionally, factors relating to time were often the most frequently reported barriers to 10 
attendance in surveys [28,38,40].  11 
Several of the influences that we identified were also recognised by healthcare providers, reported in 12 
a literature review assessing clinicians’ views towards postpartum testing [41] and by three of the 13 
studies analysed here [32,36,37]. In particular, clinicians considered that mothers should take more 14 
responsibility for their diabetes risk, and they were hindered by incomplete knowledge of their 15 
patients’ pregnancy history. While there is agreement that long-term follow-up should take place in 16 
primary care, there is inconsistency and lack of clarity regarding responsibility for short-term follow-17 
up [41,42]. In line with many clinical guidelines, one survey found that primary care was GPs’ and 18 
mothers’ preferred place for postpartum testing [40], yet others reported that if a postpartum test 19 
ordered by obstetric care was positive, the patient would have been discharged by the time the result 20 
was received and secondary care would be unable to follow-up [36].  21 
IMPLICATIONS  22 
An important aspect of many of the recommendations is developing women’s understanding of both 23 
the necessity and procedure of screening therefore increasing capability and motivation. Positively, 24 
many report awareness of the risk of developing Type 2 diabetes [29,31,33,34,36,38] but this did not 25 
always sufficiently impact on screening attendance. We therefore suggest reinforcing the following 26 
key messages to address different perspectives and promote screening, without false assurance or 27 
exaggerated concern: 28 
1. Having had GDM means you are at a higher risk of developing of Type 2 diabetes, which 29 
is a serious condition (addressing apathy); 30 
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2. We want to diagnose diabetes early (apathy) but, typically, it is initially asymptomatic so 1 
formal testing is needed. This differs from the glucose monitoring in pregnancy (self-2 
testing reassurance); 3 
3. We can manage diabetes effectively through medication and changes to lifestyle. Early 4 
diagnosis improves long-term outcomes (fear) and knowing your diagnosis enables 5 
proactive management of your health (using proactiveness); 6 
4. Blood glucose control usually returns to normal after delivery but this needs to be checked 7 
postpartum as part of routine GDM follow-up (informing risk perception); 8 
5. Diabetes can affect subsequent pregnancies (tested for other reasons). 9 
Since sharing this information is already included in many guidelines about diabetes, communication 10 
must be optimised to increase understanding. It could be provided as a guide through and beyond 11 
GDM using specifically developed wording. It could refer back to experiences from pregnancy in order 12 
to improve relatability and understandability (e.g., postpartum testing could be described in relation 13 
to pregnancy OGTTs). This information could be available to pregnant women and their clinicians in 14 
order to reduce fragmentation of care and confusion over who is responsible for testing. 15 
Additionally, we suggest several changes to healthcare provision that may increase screening. Aside 16 
from improving clinicians’ awareness of agreed protocols, steps could be taken to adapt usual practice 17 
to remove some barriers to screening. Systematic reviews have found that reminders and recall 18 
systems, such as phone calls or letters to both mothers and GPs, are associated with higher uptake of 19 
screening than usual care [10,11]. However, a recent evaluation from the Australian National 20 
Gestational Diabetes Register, a much larger cohort, suggested that mail outs had negligible impact 21 
on postpartum and annual follow-up [43]. While the reasons for this warrant investigation, the 22 
authors suggest that more personalised, local invitations might be more effective than national recall. 23 
Furthermore, one study reported mothers’ preference for electronic reminders, particularly text 24 
messages (sent by the study team) [44]. Clinicians also had positive views towards reminders [41] and 25 
some advise their patients to have a blood test in the month of their child’s birthday [personal 26 
communication]. It should be considered whether combining glucose testing with other 27 
appointments, such as newborn check-ups, child vaccination schedules or cervical cancer screening in 28 
the long-term, could be both manageable for general practice and offer benefits to women.  29 
Our qualitative synthesis also supports the need for further consideration of more acceptable 30 
screening tests due to the length and inconvenience of the OGTT and the need to fast then sugar load. 31 
The HbA1c test is an accurate measure of chronic glycaemia in the general population that requires 32 
one non-fasting blood sample [45] although it is not suitable for use shortly after pregnancy and 33 
15 
 
questions about its sensitivity remain [46,47]. Similar to the change in the NICE guidelines in 2015 [8], 1 
recent guidelines in Australia and New Zealand have recommended HbA1c testing after the 2 
postpartum period. Small-scale analyses suggest that HbA1c testing can have a higher uptake than 3 
OGTTs, yet uptake remains suboptimal in the long-term [48,49]. Our findings provide additional 4 
evidence that this could reduce some motivational barriers to screening and make it easier to 5 
complete alongside other tests or appointments. In addition, novel strategies such as very early 6 
postpartum testing (e.g. before leaving hospital) could be considered. Although less accurate than a 7 
test at six weeks, very high uptake can be achieved and therefore high-risk women can be identified 8 
for targeted follow-up [50]. Further research over longer periods is needed to evaluate the benefits 9 
and harms of increased use of other tests. 10 
CONCLUSION 11 
After a pregnancy with GDM, difficulties associated with attending appointments and a focus on the 12 
family can affect women’s ability to attend glucose testing postpartum and in the long-term. Concern 13 
about risk of developing diabetes and experiences of healthcare can increase or limit intentions 14 
towards testing. Alongside clearer education about GDM, we have suggested that amendments to 15 
healthcare provision during and after pregnancy will decrease barriers to testing. Higher uptake will 16 
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Table 2: Ten recommendations for promoting postpartum glucose testing after gestational 1 
diabetes, and our confidence in each recommendation made using the GRADE-CERQual 2 
approach 3 
Recommendation Behaviour change 
techniques relating to 
recommendation [23] 
Confidence in evidence and explanation 
Relationship with healthcare 
1. Educate clinicians to, and how to, 
promote screening throughout 
GDM and subsequent care 
1.1 Goal setting (behaviour), 
4.1 Instruction on how to 
perform the behaviour, 
9.1 Credible source 
High: Lack of information (during 
pregnancy and postpartum) and 
seemingly conflicting advice about 
postpartum screening from clinicians were 
clearly reported, while the opposite 
encouraged screening 
2. Implement recall systems for 
postpartum testing from general 
practice or obstetric care, and 
send reminders to non-
responders/for missed 
appointments 
1.4 Action planning, 
1.6 Discrepancy between 
current behaviour and goal, 
2.2 Feedback on behaviour 
High: Benefits or anticipated benefits of 
invitations and reminders were reported 
in many studies 
3. Establish standard protocols for 
communicating gestational 
diabetes history within the 
healthcare system 
12.5 Adding objects to the 
environment [for clinicians 
only] 
Moderate: There was a clear need to 
ensure sharing of patient history within 
the healthcare system, which would 
improve follow-up care; one benefit may 
be improved screening uptake 
4. Promote patient-centred 
approaches to care in order to 
facilitate building relationships and 
opportunities to ask questions 
4.1 Instruction on how to 
perform the behaviour [for 
clinicians only], 
9.1 Credible source 
Moderate: Improving experience of care 
would make it more pleasant and may 
improve screening attendance (directly or 
indirectly) 
The appointment and test 
5. Make clinics more child and 
nursing-friendly, and encourage 
mothers to bring children to 
appointments 
1.4 Action planning, 
12.1 Restructuring the 
physical environment,  
12.5 Adding objects to the 
environment 
Moderate: It is clear that clinics/long 
appointments are not considered suitable 
places to bring children but how to 
improve this was rarely discussed in the 
studies 
6. Seek innovative, personalised 
options to make it easier for hard-
to-reach women to attend testing 
(eg. drop-ins, alternative locations) 
12.1 Restructuring the 
physical environment 
Moderate: Too inconvenient 
appointments discouraged testing but the 
studies did not clearly suggest alternatives 
7. Utilise more pleasant, less time-
consuming testing procedures and 
protocols 
None  Moderate: OGTTs discourage screening; a 
shorter test without fasting or a glucose 
drink is desired and may increase uptake 
Personal and family-related practicalities 
8. Schedule postpartum glucose 
testing to coincide with other 
postpartum check-ups (both 
mothers’ and children’s 
appointments) 
10.5. Social incentive, 
10.7. Self-incentive 
Low: Glucose tests were difficult to 
attend; it is assumed that combing them 
with appointments that women are more 
motivated to attend would facilitate 
attendance 
Concern about diabetes 
25 
 
9. Educate women about the 
purpose of screening and how the 
procedure works 
4.1 Instruction on how to 
perform a behaviour, 
5.1 Information about 
health consequences 
High: Often knowledge of the purpose of 
screening increased attendance; apathy 
and fear of diagnosis were barriers but 
could be reduced through education 
10. Educate women that postpartum 
self-testing, behaviour compliance 
or one negative test result is not 
sufficient to rule out T2D in the 
long term 
5.1 Information about 
health consequences 
Moderate: Many studies explored how 
postpartum self-testing influenced 
concern about diabetes; education that 
this is not sufficient to rule out diabetes 
could increase screening attendance 
GDM: gestational diabetes; OGTT: oral glucose tolerance test; T2D: type 2 diabetes.  1 
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FIGURE CAPTIONS AND FOOTNOTES 1 
Figure 1: Example of the development of the analytical theme “Relationship with healthcare” within 2 
the thematic synthesis 3 
Not all codes were presented for simplicity. 4 
GDM: gestational diabetes; T2D: type 2 diabetes. 5 
 6 
Figure 2: PRISMA diagram showing number of studies included at each stage of the literature review 7 
* Two of these publications report the same set of interviews using different approaches to the analysis. 8 
 9 
Figure 3: Summary of the themes and subthemes of influences on attendance at postpartum glucose 10 
testing after gestational diabetes  11 
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 Table S1: Medline search strategy 17 
 Table S2: Findings from the Critical Skills Appraisal Programme (CASP) checklist  18 
 Table S3: Studies contributing to each theme  19 
 Table S4: CERQual qualitative evidence profile of recommendations for promoting attendance 20 
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SUPPLEMENTARY TABLE 1: Medline search strategy 
1. type 2 diabetes.mp. or Diabetes Mellitus, Type 2/ 
2. T2DM.mp. 
3. NIDDM.mp. or Diabetes Mellitus, Type 2/ 
4. non insulin dependent diabetes.mp. 
5. glucose tolerance.mp. 
6. insulin resistance.mp. or Insulin Resistance/ 
7. 1 or 2 or 3 or 4 or 5 or 6 
8. gestational diabet*.mp. 
9. diabetes in pregnancy.mp. 
10. Pregnancy/ or pregnancy.mp. 
11. type 2 diabet*.mp. 
12. 10 and 11 
13. gestation*.mp. 
14. 11 and 13 
15. postpartum diabet*.mp. 
16. postpartum.mp. or Postpartum Period/ 









26. health promotion.mp. or Health Promotion/ 
27. Exercise/ or exercise.mp. 
28. active living.mp. 
29. metformin.mp. or Metformin/ 
30. weight.mp. or "Weights and Measures"/ 
31. risk factors.mp. or Risk Factors/ 
32. Insulin/ or insulin.mp. 
33. exercise therapy.mp. or Exercise Therapy/ 
34. intervention.mp. 
35. interven*.mp. 
36. yoga.mp. or Yoga/ 
37. postnatal.mp. 
38. diet.mp. or Diet/ 
39. healthy eating.mp. or Healthy Diet/ 
40. behaviour.mp. 
41. physical activity.mp. or Exercise/ 
42. lifestyle.mp. or Life Style/ 
43. manag*.mp. 
44. screening.mp. or Mass Screening/ 
45. hypoglycaemic agents.mp. 
46. hypoglycaemics.mp. 
47. health promotion.mp. or Health Promotion/ 
48. medication.mp. 
49. medical therapy.mp. 
50. rate.mp. 
51. predictor*.mp. 
Women’s views on screening for type 2 diabetes after gestational diabetes: A systematic review, qualitative synthesis and 




54. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 
or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 
51 or 52 or 53 
55. follow-up.mp. 
56. postpartum.mp. or Postpartum Period/ 
57. qualitative.mp. 
58. Interview/ or interview.mp. 
59. focus group*.mp. 




64. 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 
65. 7 and 17 and 64 
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SUPPLEMENTARY TABLE 2: Findings from the Critical Skills Appraisal 




































































































































































































































Soares 2006           3.5 
Bennet 2011           8.5 
Sterne 2011           5.5 
Lie 2013           8.0 
Abraham 2014           7.0 
Morrison 2014           6.5 
Paez 2014           8.0 
Kilgour 2015           9.0 
Nielsen 2015           10.0 
Bernstein 2016           6.5 
Campbell 2017           9.0 
Pennington 2017           8.0 
Rafii 2017a           7.5 
Rafii 2017b           9.5 
Svensson 2017           7.5 
Zulfiqar 2017           7.5 
Score 
frequency 
Yes 15 15 13 11 12 2 6 10 13 5 
 Unclear 1 1 3 5 3 3 10 4 2 7 
No 0 0 0 0 1 11 0 2 1 4 
Green dot: yes (1 point); yellow dot: can’t tell/unclear (0.5 points); red dot: no (0 points)
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SUPPLEMENTARY TABLE 3: Studies contributing to each theme  
  
Relationship with healthcare 
Appointment 
and test 




















































































































































































































































































Soares 2006 3.5              
Bennet 2011 8.5              
Sterne 2011 5.5              
Lie 2013 8.0              
Abraham 2014 7.0              
Morrison 2014 6.5              
Paez 2014 8.0              
Kilgour 2015 9.0              
Nielsen 2015 10.0              
Bernstein 2016 6.5              
Campbell 2017 9.0              
Pennington 2017 8.0              
Rafii 2017a 7.5              
Rafii 2017b 9.5              
Svensson 2017 7.5              
Zulfiqar 2017 7.5              
Large dot: CASP score ≥8.5, medium dot: 7.5–8.0 (median=7.75), small dot: ≤7.0.  
Open dots indicate where a study briefly contributes to the theme, or lists the theme 
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SUPPLEMENTARY TABLE 4: CERQual qualitative evidence profile of recommendations for promoting attendance at diabetes screening after gestational diabetes 
Objective: To systematically synthesise the literature focussing on the views of women with a history of GDM on attendance at postpartum glucose testing 
Perspective: Views, experiences and ideas of any women who have had GDM during any previous pregnancy 
Included studies: Studies that examine women’s postpartum experiences following GDM relating to attendance at postpartum glucose testing 
Review recommendation Studies directly 









Relationship with healthcare 
1 Educate clinicians to, and 
how to, promote screening 





Nielsen, Paez, Rafii 
a, Sterne, 
Svensson, Zulfiqar 
Minor concerns: the highest 
quality studies contributed most 
to informing this 
recommendation 
Minor concerns: these findings 
addressed attitudes towards 
screening (rather than general 
healthcare seeking, which was 
also sometimes considered) 
Minor concerns: for many 
participants, clinicians played 
the key part in forming views 
toward screening 
Minor concerns: several studies 
discussed in detail how women 
interpreted (lack of) information 
and others more briefly 
mentioned this idea  
High confidence Lack of information 





from clinicians were 
clearly reported, while 
the opposite 
encouraged screening 
2 Implement recall systems for 
postpartum testing from 
general practice or obstetric 





Pennington, Rafii a, 
Rafii b, Sterne, 
Zulfiqar 
Minor concerns: the highest 
quality studies contributed most 
to informing this 
recommendation 
No or very minor concerns: 
these findings clearly 
addressed attitudes towards 
arranging the screening test 
(rather than general healthcare 
seeking, which was also 
sometimes considered) 
Minor concerns: invitations from 
clinicians were reported 
positively; participants wanted 
reminders; many took control of 
arranging tests but reported this 
negatively  
Minor concerns: several studies 
discussed arranging tests: the 
majority discussed difficulties 
when they didn’t receive 
support but some discussed 
invitations and reminders 
helping 
High confidence Benefits or anticipated 
benefits of invitations 
and reminders were 
reported in many 
studies  
3 Establish standard protocols 
for communicating 
gestational diabetes history 




Minor concerns: four high and 
two good quality studies 
contributed to this 
recommendation; two studies 
considered the researcher-
participant relationship so this 
may have influenced the 
discussion about the healthcare 
system in the others  
Minor concerns: these findings 
were relevant to postpartum 
follow-up including screening  
Moderate concerns: six studies 
clearly discussed fragmented 
care and women as information 
brokers, which lead to 
postpartum abandonment and 
getting lost between 
specialities; one explained how 
this discouraged screening 
attendance  
Moderate concerns: data 
regarding women’s discussion 
of continuity of care were rich 
but explanations on the 




There was a clear need 
to ensure sharing of 
patient history within 
the healthcare system, 
which would improve 
follow-up care;  one 
benefit may be 
improved screening 
uptake 
4 Promote patient-centred 
approaches to care in order 
to facilitate building 
relationships and 
opportunities to ask 
questions 






No or very minor concerns: the 
studies that directly contributed 
to this recommendation were 
the highest quality 
Minor concerns: these findings 
were relevant to postpartum 
follow-up including screening 
Moderate concerns: it is clear 
and logical that patient-centred 
care improves healthcare 
experience but less clear from 
these studies that screening 
attendance would increase as a 
result  
Moderate concerns: few studies 
contributed directly to this 
recommendation, however, all 
of the studies that discuss the 
healthcare system inform 




Improving experience of 
care would make it 
more pleasant and may 
improve screening 
attendance (directly or 
indirectly) 
The appointment and test 
5 Make clinics more child and 
nursing-friendly, and 
encourage mothers to bring 
children to appointments 
Bennett, Kilgour, 
Paez, Rafii a, 
Sterne 
Moderate concerns: four 
studies were very high quality 
but Sterne contributed most to 
this theme and had many 
methodological limitations  
Minor concerns: these findings 
were relevant to postpartum 
follow-up and screening 
appointments 
Moderate concerns: it was clear 
that many women did not 
consider taking the baby to the 
appointment so struggled to go 
if they couldn’t find childcare; 
some participants suggested 
improving clinic environments 
Moderate concerns: data about 
the need for childcare were 
rich, but there were fewer data 
about changing clinic 




It is clear that 
clinics/long 
appointments are not 
considered suitable 
places to bring children 
but how to improve this 
was rarely discussed in 
the studies 
6 Seek innovative, 
personalised options to 
make it easier for hard-to-
reach women to attend 




Rafii a, Rafii b, 
Sterne 
Minor concerns: several high 
quality studies contributed most 
to informing this 
recommendation 
Minor concerns: these findings 
were relevant to postpartum 
follow-up and screening 
appointments 
Moderate concerns: how 
easy/convenient it was to 
attend the test affected uptake, 
highlighting this as an area for 
improvement; one study 
suggesting home testing 
Moderate concerns: data about 
the inconvenience of testing 
were rich but how to improve it 





discouraged testing but 
the studies did not 
clearly suggest 
alternatives 
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Recommendations frequently result from findings within multiple themes but have been presented under the primary contributing theme. Only studies directly contributing to the recommendation have been cited 
GDM: gestational diabetes; OGTT: oral glucose tolerance test; T2D: type 2 diabetes 
7 Utilise more pleasant, less 
time-consuming testing 
procedures and protocols 
Bernstein, Paez, 
Pennington, Rafii a, 
Sterne 
Moderate/minor concerns: two 
of the five studies contributing 
to this theme were low quality 
but this is not expected to have 
a large impact on this 
recommendation 
No or very minor concerns: 
these findings clearly 
addressed attitudes towards 
arranging the screening test 
Moderate concerns: the need to 
fast, drink a glucose drink and 
wait were clear barriers to the 
OGTT and alternative tests 
were suggested, but no studies 
showed increased attendance 
using alternative tests 
Minor concerns: the data 
provide a clear understanding 





screening; a shorter 
test without fasting or a 
glucose drink is desired 
and may increase 
uptake 
Family-related practicalities 
8 Schedule postpartum 
glucose testing to coincide 
with other postpartum 
check-ups (both mothers’ 







Rafii a, Rafii b 
No or very minor concerns: the 
studies that directly contributed 
to this recommendation were 
the highest quality 
No or very minor concerns: 
these findings clearly 
addressed attitudes towards 




appointments for other reasons 
(eg. for vaccinations or to 
discuss contraception) and Rafii 
b describes ‘accidental 
screening’, therefore we only 
assume that combined 
appointments are more 
convenient and worth attending  
Major concerns: only a few 
studies contributed to this 
theme, plus general 
inconvenience of appointments 
and motivation to attend  
Low confidence Glucose tests were 
difficult to attend; it is 
assumed that combing 
them with appointments 
that women are more 
motivated to attend 
would facilitate 
attendance 
Concern about diabetes 
9 Educate women about the 
purpose of screening and 




Lie, Nielsen, Paez, 
Rafii a, Rafii b, 
Sterne, Zulfiqar 
Minor concerns: mostly high 
quality studies contributed to 
this recommendation 
Minor concerns: these findings 
showed that apathy and fear of 
diagnosis acted as a barrier to 
screening and understanding 
the need for screening as a 
facilitator to screening 
attendance specifically 
Minor concerns: findings show 
that knowledge about the 
purpose of screening increased 
attendance and so it is clear 
and logical that education of 
women on the purpose of 
screening should increase 
attendance 
Minor concerns: several studies 
discuss the themes contributing 
to this recommendation in detail 
High confidence Often knowledge of the 
purpose of screening 
increased attendance; 
apathy and fear of 
diagnosis were barriers 
but could be reduced 
through education 
10 Educate women that 
postpartum self-testing, 
behaviour compliance or 
one negative test result is 
not sufficient to rule out T2D 
in the long term 
Bennett, Bernstein, 
Kilgour, Lie, 
Nielsen, Paez, Rafii 
a, Rafii b 
Minor concerns: mostly high 
quality studies contributed to 
this recommendation 
Minor concerns: these findings 
were relevant predominantly to 
postpartum screening, but did 
include other aspects of post-
partum behaviour such as diet 
Minor concerns: use of 
glucometer postpartum 
consistently discouraged 
screening attendance in these 
studies 
Moderate concerns: four of the 
studies discuss the impact of 
self-testing on screening 
attendance whilst remaining 
have sparse findings 
addressing role of reassurance 




Many studies explored 
how postpartum self-
testing influenced 
concern about diabetes; 
education that this is 
not sufficient to rule out 
diabetes could increase 
screening attendance 
